Ketamine and Traditional Antidepressants: How Treatment Approaches Differ

Important: Compounded ketamine is not FDA-approved. FDA has not evaluated its safety, effectiveness, or quality before marketing. Ketamine injection is approved for anesthesia, not psychiatric conditions. Compounded ketamine nasal spray is different from FDA-approved Spravato (esketamine), and research on other formulations or treatment settings does not establish its benefits.

Traditional antidepressants and ketamine are often compared as if each were a single, uniform treatment. In practice, there are many antidepressant medications and several very different ketamine-related products. A useful comparison starts by naming the actual options.

Different mechanisms do not prove superiority

SSRIs affect serotonin signaling. Ketamine acts at NMDA receptors, which are part of glutamate signaling. These are descriptions of biological activity, not a test that can identify the right treatment for a person. A different mechanism does not establish that ketamine is more effective, safer, or free of an antidepressant’s unwanted effects.

For background, see MedlinePlus information on fluoxetine, an SSRI and the ketamine injection label. Neither source supports treating all depression as a simple chemical deficiency or promising that ketamine repairs its underlying cause.

Compare the day-to-day plan

Ask how a medication fits into everyday care: whether you take it regularly, what follow-up is needed, how side effects are assessed, and what restrictions apply. Also ask about the treatment setting. An infusion clinic, a certified esketamine setting, and a home prescription do not offer identical supervision.

Descriptions of a gentle infusion or a brief floaty feeling can understate impairment and serious adverse effects. Your care team should explain the actual risks and instructions rather than rely on reassuring adjectives.

Review previous treatment before changing it

Write down which medications you tried, their duration, what improved, and what made them difficult to continue. Include changes in sleep, mood, concentration, sexual function, and daily activities. This helps the clinician distinguish a lack of benefit from problems that may be addressed by modifying the care plan.

Do not abruptly stop or taper an antidepressant on your own to make room for ketamine. Ask who will coordinate care if more than one clinician is involved. Any change should include a plan for withdrawal symptoms, symptom recurrence, and follow-up.

The most relevant question is which well-explained plan fits your situation, given its evidence and uncertainty. There is no universal winner across all patients or formulations.

Safety and the treatment setting

Ketamine can cause sedation, dissociation, impaired thinking or coordination, nausea, increased blood pressure or heart rate, and slowed breathing. Abuse or misuse, worsening psychiatric symptoms, and urinary or bladder problems are also concerns. This is not a complete list of risks.

At home, a healthcare professional is not onsite to monitor you or respond immediately to an adverse reaction. Telehealth support does not provide the same monitoring as an onsite care team. Review these FDA ketamine risk alerts and discuss your health history, other medications, monitoring needs, and emergency plan with your clinician.

Discuss your options

Bliss Mist Rx LLC provides telehealth services; we do not manufacture or compound medication. If a clinician prescribes treatment, an independent, appropriately licensed compounding pharmacy dispenses it. A consultation does not guarantee a prescription or a particular outcome. Book a Free Virtual Appointment or Follow-Up to discuss questions about your care.

This article is general education and does not replace individualized medical advice.